Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Atorvastatin in Episodic Migraine
NCT06248671Phase 2Recruiting
- Sponsor
- St. Olavs University Hospital
- Start
- May 2024
- Primary completion
- Dec 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atorvastatin in episodic migraine, sponsored by St. Olavs University Hospital. Started May 2024; status: recruiting.
02
Drugs
atorvastatin
03
Conditions
episodic migraine
Beyond the preview
Go deeper on NCT06248671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06248671.